Back
Spyre Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
SYRE
Spyre Therapeutics, Inc.
Last Price:
$43.00
Seasonality Move:
-6.34%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing slight selling pressure.
Spyre Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.91 | Buy |
| 20-day SMA: | 37.12 | Buy |
| 50-day SMA: | 34.37 | Buy |
| 200-day SMA: | 22.96 | Buy |
| 8-day EMA: | 37.04 | Buy |
| 20-day EMA: | 23.32 | Buy |
| 50-day EMA: | 11.53 | Buy |
| 200-day EMA: | 3.23 | Buy |
Spyre Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 11.95 | Buy |
| Relative Strength Index (14 RSI): | 71.18 | Buy |
| Chaikin Money Flow: | -20381 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.96 - 40.58) | Buy |
| Bollinger Bands (100): | (23.49 - 36.09) | Buy |
Spyre Therapeutics, Inc. Technical Analysis
| Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Spyre Therapeutics, Inc. Stock
Is Spyre Therapeutics, Inc. Stock a Buy?
-
Spyre Therapeutics, Inc. share price is 43.01 while SYRE 8-day simple moving average is 41.91, which is a Buy signal.
-
The stock price of SYRE is 43.01 while Spyre Therapeutics, Inc. 20-day SMA is 37.12, which makes it a Buy.
-
Spyre Therapeutics, Inc. 50-day simple moving average is 34.37 while SYRE share price is 43.01, making it a Buy technically.
-
SYRE stock price is 43.01 and Spyre Therapeutics, Inc. 200-day simple moving average is 22.96, creating a Buy signal.
SYRE Technical Analysis vs Fundamental Analysis
Buy
68
Spyre Therapeutics, Inc. (SYRE)
is a Buy
Is Spyre Therapeutics, Inc. a Buy or a Sell?
-
Spyre Therapeutics, Inc. stock is rated a BuyThe current Spyre Therapeutics, Inc. [SYRE] share price is $43.01. The Score for SYRE is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Spyre Therapeutics, Inc. Stock Info
Market Cap:
3.4B
Price in USD:
43.01
Share Volume:
695.2K
Spyre Therapeutics, Inc. 52-Week Range
52-Week High:
45.76
52-Week Low:
10.91
Buy
68
Spyre Therapeutics, Inc. (SYRE)
is a Buy
Spyre Therapeutics, Inc. Share Price Forecast
-
What is the Spyre Therapeutics, Inc. stock price today?The Spyre Therapeutics, Inc. stock price is 43.01 USD today.
-
Will SYRE stock go up or go down?Spyre Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Spyre Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Spyre Therapeutics, Inc. is not overvalued.
Is Spyre Therapeutics, Inc. Stock a Buy?
-
Spyre Therapeutics, Inc. share price is 43.01 while SYRE 8-day exponential moving average is 37.04, which is a Buy signal.
-
The stock price of SYRE is 43.01 while Spyre Therapeutics, Inc. 20-day EMA is 23.32, which makes it a Buy.
-
Spyre Therapeutics, Inc. 50-day exponential moving average is 11.53 while SYRE share price is 43.01, making it a Buy technically.
-
SYRE stock price is 43.01 and Spyre Therapeutics, Inc. 200-day simple moving average is 3.23, creating a Buy signal.
Fundamental Analysis of Spyre Therapeutics, Inc.
Is Spyre Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.51 per share, a decrease this year of $0.75 per share, and a decrease next year of $0.15 per share.
Technical Analysis of Spyre Therapeutics, Inc.
Should I short Spyre Therapeutics, Inc. stock?
-
SYRE Moving Average Covergence Divergence (MACD) indicator is 11.95, suggesting Spyre Therapeutics, Inc. is a Buy
-
Spyre Therapeutics, Inc. Relative Strength Index (RSI) is 71.18, which suggest Spyre Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Spyre Therapeutics, Inc. is (31.96 - 40.58), which suggest Spyre Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Spyre Therapeutics, Inc. is (23.49 - 36.09), which suggest Spyre Therapeutics, Inc. is a Buy
* Spyre Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.